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Shiga toxin-producing Escherichia coli (STEC) are responsible for gastrointestinal
diseases reported in numerous outbreaks around the world. Given the public health
importance of STEC, effective detection, characterization and typing is critical to
any medical laboratory system. While non-O157 serotypes account for the majority
of STEC infections, frontline microbiology laboratories may only screen for STEC
using O157-specific agar-based methods. As a result, non-O157 STEC infections are
significantly under-reported. This review discusses recent advances on the detection,
characterization and typing of STEC with emphasis on work performed at the Alberta
Provincial Laboratory for Public Health (ProvLab). Candidates for the detection of all STEC
serotypes include chromogenic agars, enzyme immunoassays (EIA) and quantitative real
time polymerase chain reaction (qPCR). Culture methods allow further characterization
of isolates, whereas qPCR provides the greatest sensitivity and specificity, followed
by EIA. The virulence gene profiles using PCR arrays and stx gene subtypes can
subsequently be determined. Different non-O157 serotypes exhibit markedly different
virulence gene profiles and a greater prevalence of stx1 than stx2 subtypes compared
to O157:H7 isolates. Finally, recent innovations in whole genome sequencing (WGS)
have allowed it to emerge as a candidate for the characterization and typing of STEC
in diagnostic surveillance isolates. Methods of whole genome analysis such as single
nucleotide polymorphisms and k-mer analysis are concordant with epidemiological data
and standard typingmethods, such as pulsed-field gel electrophoresis andmultiple-locus
variable number tandem repeat analysis while offering additional strain differentiation.
Together these findings highlight improved strategies for STEC detection using currently
available systems and the development of novel approaches for future surveillance.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) encompass a heterogeneous group of enteric
pathogens responsible for numerous sporadic infections and large outbreaks worldwide. Accurate
and rapid diagnosis of STEC infections is important for the appropriate management of infected
patients and for implementation of proper public health interventions. Specifically, patients
infected with STEC should not be treated with antibiotics because of the risk of developing
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hemolytic uremic syndrome (HUS) (Wong et al., 2000, 2012;
Smith et al., 2012). Also, once STEC is identified in a patient, the
contacts and potential sources of infection must be identified to
prevent further spread of the disease. Although, laboratories have
become proficient at detecting O157:H7 infections, they often do
not screen stools for other STEC serotypes. This creates a gap
in diagnostics; since 50% or more of STEC infections may be
caused by non-O157 STEC, our surveillance and understanding
of the epidemiology of STEC disease is incomplete (Fey et al.,
2000; Jelacic et al., 2003; Thompson et al., 2005; Chui et al., 2011;
Couturier et al., 2011; Scallan et al., 2011; Gould et al., 2013;
STEC, National Surveillance Summary, 2014).
Growing recognition of the shortfall in STEC detection
has prompted a shift toward more comprehensive STEC
identification methods. Bacteriological culture remains the gold
standard test, given the importance of identifying viable bacterial
isolates for typing. For this reason, there has been increased
development and use of agars which also select for non-O157
STEC (Kase et al., 2015). However, as culture-based methods
are laborious and exhibit clear limits in sensitivity for STEC
detection, it is recommended that laboratories supplement
culture-based approaches with other assay types (Gould et al.,
2009).
Alongside culture-based STEC testingmany laboratories assay
for the presence of Shiga toxins (Stx) or the stx genes. Shiga
toxin was originally referred to as verotoxin for its cytotoxic
effect on Vero cells (Konowalchuk et al., 1977). Once Stx was
linked to hemorrhagic colitis and HUS, researchers developed
cytotoxicity assays to detect Stx from both fecal specimens as well
as from enriched stool cultures containing polymyxin B (Karmali
et al., 1985). While such laborious cytotoxicity assays remain a
method of diagnosis for some laboratories, detection of Stx or
the presence of the stx genes is now primarily done in clinical
laboratories by enzyme immune assay (EIA) of some form, or by
polymerase chain reaction (PCR)-based approaches, respectively.
These methods can also determine if Stx1 or 2 are present,
which adds prognostic value, since there is a well-documented
correlation of Stx2 with the clinical severity of STEC infection
and the risk of HUS (Schimmer et al., 2008; Soon et al., 2013;
Chui et al., 2015a).
While advancements in the sensitivity and speed of STEC
detection have direct implication on the diagnosis and treatment
of diarrheal illnesses, characterization of STEC isolates
beyond serotype or individual virulence factors is required
for prevention, control and prediction of STEC infections on
a public health scale. The requirement for high resolution
typing of STEC is also increasingly necessary given the observed
emergence of diverse types of virulent strains (Soon et al., 2013).
Current STEC fingerprinting techniques such as pulsed-field
gel electrophoresis (PFGE) or multi-locus variable number
tandem repeat analysis (MLVA) using the PulseNet International
protocol allow comparison of strains from different countries
and aid in the epidemiological tracking of STEC infections
around the world, especially during outbreak settings (Sabat
et al., 2013). While methods such as PFGE and MLVA play a
crucial role in current outbreak investigations, the increasingly
tractable use of whole genome sequencing (WGS) has garnered
significant interest as a powerful method for typing bacterial
pathogens (Chattaway et al., 2016). WGS technologies promise
typing resolution at orders of magnitude greater than existing
methods. Yet, as technical capabilities improve for STEC
typing, new challenges arise surrounding implementation,
standardization and management of typing data (Köser et al.,
2012; Franz et al., 2014).
Here we present an overview of recent advances and the
experiences at the Provincial Laboratory of Public Health
(ProvLab) in Alberta Canada with various bacteriological,
molecular and genomic strategies for detection and typing of
STEC. We assess the benefits and shortcomings of various
methods used in the detection and differentiation of STEC.
Through evaluation of available systems and opportunities
for novel approaches, this review aims to identify improved
strategies for STEC identification and surveillance.
DIFFERENTIAL AND SELECTIVE MEDIA
When E. coli O157:H7 was first identified as an etiologic
agent of hemorrhagic colitis, it was discovered to be unlike
most other strains of E. coli, because it could not ferment
sorbitol (Wells et al., 1983; Pai et al., 1984). This biochemical
peculiarity led to the use of sorbitol-MacConkey (SMAC) agar to
identify non-sorbitol fermenting E. coli in stool of patients with
bloody diarrhea (Remis, 1984). This agar differed from typical
MacConkey agar by substituting lactose with sorbitol; non-
sorbitol fermenting organisms produced white colonies on the
medium (Remis, 1984). Early investigations found that SMAC
agar displayed acceptable sensitivity, specificity, and negative
predictive value (NPV) for E. coli O157:H7 detection, but a
positive predictive value (PPV) of only 28% (Table 1; March
and Ratnam, 1986). Besides its low PPV, other limitations of
SMAC include its inability to detect non-O157 STEC as well
as sorbitol-fermenting O157 STEC isolates, which can carry the
toxigenic stx genes and cause outbreaks (Gunzer et al., 1992;
Ammon et al., 1999). To improve the detection of STEC, a new
chromogenic medium, CHROMagarTM O157, was developed by
CHROMagar Microbiology (CHROMagarTM O157 CHROMagar
Microbiology, Paris, France, 2013). Through the incorporation
of proprietary chromogenic substrates in CHROMagarTM O157
agar, O157 STEC appear mauve while other E. coli are blue.
Unfortunately, as with SMAC agar, CHROMagarTM O157 is not
able to detect most non-O157 STEC (Bettelheim, 1998). The only
study directly comparing SMAC agar to CHROMagarTM O157
showed that CHROMagar
TM
O157 had a lower false-positive rate
for colony picks (20%) compared to that of SMAC agar (65%) as
well as estimated annual cost-savings of approximately $76,000 in
a large Canadian clinical laboratory (Church et al., 2007). In the
same study, CHROMagarTM O157 had a higher sensitivity (96.3%
vs. 85.2%) for detectingO157 STEC (Table 1; Church et al., 2007).
Other chromogenic media, such as ColorexTM O157 (Alere, Inc.,
Ottawa, ON, Canada), are also available to detect O157 STEC, but
have not been clinically evaluated.
Many clinical microbiology laboratories continue to use
either SMAC agar or CHROMagar
TM
O157 exclusively to detect
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TABLE 1 | Summary of clinically evaluated STEC detection methods.
Assay Description Sensitivity/Specificity PPV/NPV References
SOLID MEDIA
CHROMagarTM O104
STEC
Detects O104:H4 STEC through chromogenic
substrate
71.4%/99.1% 62.5%/99.4% Gouali et al., 2013
CHROMagarTM O157 Detects O157 STEC through a chromogenic
substrate
96.3%/100% 100%/100% Church et al., 2007
CHROMagarTM STEC Detects O157 and non-O157 STEC through a
chromogenic substrate
84.6–85.7%/87–95.8% 13.9–60%/98.9–
99.6%
Wylie et al., 2013; Zelyas et al., 2016
Rainbow® Agar O157 Detects O157 and some non-O157 STEC
through β-glucuronidase and β-galactosidase
activities
Not determined Not determined Zelyas et al., 2016
Sorbitol-MacConkey Detects O157 STEC by lack of sorbitol
fermentation
85.2–100%/85–100% 28–100%/99.9–
100%
March and Ratnam, 1986; Church
et al., 2007
TOXIN DETECTION
BioStar SHIGATOX Optical immunoassay detects and
differentiates Stx1/2
96.8%/99.4% 88.2%/99.9% Church et al., 2007
Duopath Verotoxin-test
TM
Immunochromatographic assay detects and
differentiates Stx1/2
88.9%/71.4% 42.1%/96.5% Grif et al., 2007
Immunocard STAT!® Immunochromatographic assay detects and
differentiates Stx1/2
35.5%/99.4% 54.5%/98.6% Chui et al., 2013
Premier® EHEC Microwell EIA detects Stx1/2 without toxin
differentiation
90.5–96.8%/98.5–
100%
76.2–100%/98–
99.9%
Grif et al., 2007; Teel et al., 2007;
Chui et al., 2011; Hermos et al., 2011
ProSpect
TM
Shiga Toxin
E. coli
Microwell EIA detects Stx1/2 without toxin
differentiation
76.8%/100% 100%/96.1% Gerritzen et al., 2011
Shiga Toxin Chek
TM
Microwell EIA detects Stx1/2 without toxin
differentiation
80%/98.2% 53.3%/99.5% Chui et al., 2015b
Shiga Toxin Quik Chek
TM
Immunochromatographic assay detects and
differentiates Stx1/2
85%/100% 100%/99.6% Chui et al., 2015b
MOLECULAR DETECTION
EntericBio real-time
Gastro Panel I®
Multiplex PCR detects four pathogens
including STEC
100%/99.8% 82.9%/100% Koziel et al., 2013
FilmArray® GI panel Array-based multiplex PCR detects 22
pathogens including STEC
100%/99.1–99.6% 86.8–
95.1%/100%
Khare et al., 2014; Buss et al., 2015
Seeplex® Diarrhea ACE
Detection
Multiplex PCR with dual priming
oligonucleotide technology detecting 14
pathogens including STEC
100%/99.6–100% 66.7–100%/100% Coupland et al., 2013; Onori et al.,
2014
TaqMan® in-house STEC
detection assay
Real-time PCR assay developed by Alberta
ProvLab detecting stx1 and stx2 separately
100%/100% 100%/100% Chui et al., 2010
xTag® Gastrointestinal
Pathogen Panel
Multiplex PCR with bead hybridization
detecting 15 pathogens including STEC
93.5–100%/98.8–
100%
75–100%/99.1–
100%
Claas et al., 2013; Navidad et al.,
2013; Deng et al., 2015
PPV, positive predictive value; NPV, negative predictive value; for CHROMagarTM O104 STEC, diagnostic values are for O104:H4 STEC only; for CHROMagarTM O157 and
sorbitol-MacConkey, diagnostic values are for O157:H7 STEC only; for all other assays, diagnostic values are for all STEC serotypes.
STEC even though they are not appropriate for the detection
of non-O157 STEC. Guidelines released by the Centers for
Disease Control and Prevention (CDC) specify that laboratories
are to simultaneously culture stool specimens for O157 STEC
and test them with an assay that detects non-O157 STEC
(Gould et al., 2009). Because of the shortcomings of SMAC
and CHROMagar
TM
O157, there has been interest in creating a
medium capable of detecting non-O157 serotypes of STEC.
During the 2011 E. coli O104:H4 outbreak in Europe, a
medium specifically designed to detect the outbreak strain,
CHROMagar
TM
STEC O104, was developed (Gouali et al., 2013).
While this agar is able to detect the O104:H4 strain expressing
an extended-spectrum β-lactamase (ESBL) initially causing the
outbreak, it is unable to detect other non-O157 serotypes and
O104:H4 isolates that have lost the plasmid encoding the ESBL
(Mariani-Kurkdjian et al., 2011; Grad et al., 2012). Its utility is
also hampered by low sensitivity and PPV (Table 1).
Other chromogenic agars capable of detecting wider ranges
of STEC serotypes have been described, including Rainbow R©
Agar O157 and CHROMagarTM STEC (Biolog, Hayward, CA,
USA, 2008; CHROMagarTM STEC, CHROMagar Microbiology,
Paris, France, 2014). CHROMagarTM STEC is meant to detect
all STEC serotypes. Like other media developed by CHROMagar
Microbiology, pathogen detection on CHROMagarTM STEC is
based on the organism’s utilization of proprietary chromogenic
substrates. CHROMagarTM STEC is able to detect most of the
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STEC serotypes for which it has been assessed (Hirvonen et al.,
2012; Wylie et al., 2013; Zelyas et al., 2016). Direct inoculation
of stool onto the agar yields acceptable sensitivity, specificity,
and NPV, but the PPV is quite low (Wylie et al., 2013; Zelyas
et al., 2016). Two studies using different broth enrichment
protocols prior to inoculation showed sensitivities varying from
50% (McCallum et al., 2013) to 91.4% (Gouali et al., 2013).
Rainbow R© Agar O157 is purported to detect O157:H7,
O26:H11, O48:H21, O111:H-, and O111:H8 serotypes based
on their reduced or absent β-glucuronidase activity compared
to non-toxigenic strains (Biolog, Hayward, CA, USA, 2008).
Although, Rainbow R©Agar O157 has been evaluated in a number
of studies for the detection of STEC in food and water (Radu
et al., 2000; Tutenel, 2003; Tillman et al., 2012; Yoshitomi et al.,
2012; Ngwa et al., 2013), its ability to identify STEC from
human stool was first investigated at the Alberta ProvLab. A
study by Zelyas et al. (2016) performed at the Alberta ProvLab
compared four chromogenic agar media in their ability to
detect non-O157 STEC. Isolates from a panel of 161 non-
O157 STEC were inoculated directly onto CHROMagarTM STEC,
Rainbow R© Agar O157, CHROMagarTM O157, and Colorex R©
O157 to observe if the isolates would produce STEC-like colonies.
Unsurprisingly, CHROMagarTM O157 and Colorex R© O157 were
unable to identify the majority of non-O157 isolates as STEC,
while CHROMagarTM STEC and Rainbow R© Agar O157 had
detection rates of 90% and 70%, respectively. Using stool
cultures spiked with non-O157 STEC isolates, it was found that
CHROMagarTM STEC once again exhibited a superior detection
rate of 72% (compared to 26% using Rainbow R© Agar O157) in
bloody stool. Similar to previous studies, CHROMagarTM STEC
demonstrated a sensitivity, specificity, PPV, and NPV of 84.6,
87, 13.9, and 99.6%, respectively, when 536 clinical specimens
were inoculated directly onto the medium (Table 1). Although,
studies demonstrate that CHROMagarTM STEC shows promise
in its ability to rule out STEC in its absence, the high number
of false-positive results seen on the medium would necessitate
considerable additional laboratory testing to confirm or deny
STEC status of mauve colonies. The use of CHROMagarTM STEC
should perhaps be limited to the procurement of STEC isolates
when a stool tests positive for STEC by a non-culture method,
such as toxin or toxin gene detection. As discussed below, such
non-culture methods often display sensitivities above the ∼85%
seen with CHROMagarTM STEC.
ENZYME IMMUNOASSAYS
As no culture medium is yet available for the practical detection
of all STEC serotypes, identifying the Shiga toxin (Stx) in stools
is an alternative method of diagnosing STEC-related disease. The
first EIAs developed for Stx identified STEC colonies based on the
binding of monoclonal antibodies to Stx1 and Stx2 immobilized
on membranes (Perera et al., 1988; Milley and Sekla, 1993). Since
the creation of these early EIAs that required the growth of
isolated colonies on a solid medium, a number of other assays
have been developed for the detection of Shiga toxin directly from
stool or from enriched stool cultures.
One of the most evaluated and used EIAs is the Premier R©
EHEC microwell immunoassay (Meridian Bioscience Inc.,
Cincinnati, OH, USA). Multiple studies using overnight
broth enrichment stool cultures found that Premier R© EHEC
demonstrates high sensitivity and specificity (Table 1). Premier R©
EHEC has also been used to detect Stx directly from clinical
specimens without the use of an overnight enrichment step;
one group found this approach had a sensitivity of 83.9%
and specificity of 99.8% (Teel et al., 2007). Another microwell
immunoassay that has undergone clinical evaluation, the
ProSpectTM Shiga Toxin E. coli assay (Remel, Lenexa, KS, USA),
demonstrated inferior sensitivity compared to Premier R© EHEC
(Table 1).
Besides microwell EIAs, other types of immunoassays have
been developed to detect STEC. One such assay is the
BioStar R© SHIGATOX optical immunoassay (Inverness Medical
Professional Diagnostics, Inc., San Diego, CA, USA) which
detects Stx by its interaction with anti-Stx antibodies on the
surface of a silicon wafer; this interaction causes an increase in
the optical thickness of the thin film and results in a visible color
change on the wafer. Similarly, the Duopath Verotoxin-testTM
(Merck, Darmstadt, Germany) is an immunochromatographic
assay that employs anti-Stx antibodies immobilized to a
membrane to bind and detect Stx. In previous studies, the
BioStar R© SHIGATOX assay exhibited a superior performance to
the Duopath Verotoxin-testTM (Table 1). However, the Duopath
Verotoxin-testTM is advantageous because it differentiates
between Stx1- and Stx2-producing STEC.
Studies performed at the Alberta ProvLab have evaluated
two microwell immunoassays: the aforementioned Premier R©
EHEC and the Shiga Toxin ChekTM assay (TechLab, Inc.,
Blacksburg, VA, USA; Chui et al., 2011, 2015b). Premier R© EHEC
demonstrated a sensitivity of 90.5%, similar to that seen in
previous studies (Grif et al., 2007; Teel et al., 2007; Hermos et al.,
2011), and the Shiga Toxin ChekTM assay had a lower sensitivity
of 80%which decreased to 70%when unenriched specimens were
used (Table 1; Chui et al., 2011, 2015b).
Additionally, two immunochromatographic assays have
been assessed at the Alberta ProvLab: ImmunoCard STAT! R©
(Meridian Bioscience, Inc., Cincinnati, OH, USA) and Shiga
Toxin Quik ChekTM (TechLab, Inc., Blacksburg, VA, USA;
Chui et al., 2015b, 2013). Despite having a specificity >99%,
ImmunoCard STAT! R© had a low sensitivity of 35.5% even when
using enrichment broths (Table 1). Shiga Toxin Quik ChekTM
demonstrated sensitivities of 85 and 70% with and without
enrichment, respectively (Chui et al., 2013, 2015b).
Some caution must be exercised when using EIAs alone to
detect STEC. There have been two norovirus outbreaks in the
United States in which EIAs yielded false-positive STEC results,
highlighting the pitfall of depending on a single method to
diagnose STEC-related disease (Centers for Disease Control and
Prevention (CDC), 2001, 2006).
MOLECULAR METHODS
While the detection of Stx is a direct way to determine if clinical
specimens harbor STEC, there has been much interest in nucleic
acid-based methods to detect the presence of the stx genes in
stools. The earliest application of nucleic acid detection for STEC
involved the use of cloned portions of stx1 and stx2 as
35S-labeled
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DNAprobes in colony hybridization assays (Willshaw et al., 1987;
Scotland et al., 1988). Soon after DNA hybridization assays were
developed, a conventional PCR targeting stx1 and stx2 in a single
reaction was devised (Pollard et al., 1990); a similar assay was
later described which could detect STEC fromDNA isolated from
stool (Brian et al., 1992).
A multitude of PCR assays have been developed since and a
number of them use real-time platforms. Some of the advantages
of using real-time PCR assays include excellent sensitivity and
specificity and the ability to devise multiplex assays to detect
and differentiate between stx1 and stx2, other virulence genes
such as the intimin gene, eae, and hemolysin gene, ehx4, and
even other gastrointestinal pathogens. The first reported stx-
targeting real-time PCR assay used directly on naturally infected
clinical stool had a sensitivity of 100% and a specificity of 92%
(Bélanger et al., 2002). Numerous real-time PCR assays have been
designed and generally demonstrate similarly high detection rates
with few false positive results (Grys et al., 2009; Gerritzen et al.,
2011; Zhang et al., 2012). Commercial real-time PCR assays such
as the GeneDisc R© (GeneDisc R© Technolgies Pall Corporation,
NY, USA) and BAX R© System (DuPont Nutrition and Health,
Wilmington, DE, USA) include a panel for rapidly screening
for STEC, targeting stx1, stx2, and eae or other genes, followed
by panels that target serotype-specific genes of O157 STEC and
top six non-O157 STEC. These real-time PCR STEC panels
exhibit high sensitivity and can be applied in two step screening
algorithms that first capture STEC followed by detection the
most frequently reported STEC serotypes (Fratamico et al., 2012;
Wasilenko et al., 2014) Most real-time PCR assays use any one of
a number of available detection systems, including SYBR green,
TaqMan R©, molecular beacon probes, fluorescence resonance
energy transfer (FRET) probes, LUXTM (light upon extension)
assays with singly-labeled primers without probes, as well as other
methods. Further contributing to the heterogeneity of available
methods, different real-time PCR assays often target different
regions within stx1 and stx2, (Chui et al., 2010).
Numerous multiplex molecular assays for the detection of
multiple gastrointestinal pathogens are also available. The xTag R©
Gastrointestinal Pathogen Panel (GPP) (Luminex Corporation,
Austin, TX, USA), is FDA- and Health Canada-approved for
the detection of multiple agents of gastroenteritis. The GPP
employs a multiplex PCR with a reverse transcriptase step
intended to amplify nucleic acid from nine bacterial pathogens,
three parasites, and three viruses. The generated amplicons
are then hybridized to oligonucleotides bound to microspheres,
which are detected by the instrument. Included in the GPP are
separate targets for the detection of E. coli O157 and non-O157
STEC. Multiple evaluations performed in different regions have
demonstrated high sensitivities and specificities (Table 1). Some
studies report the detection of STEC by the GPP in culture- or
conventional PCR-negative specimens; the significance of these
results, whether due to heightened sensitivity of the GPP or
to false-positives, has not been determined (Mengelle et al.,
2013; Vocale et al., 2015). The EntericBio real-time Gastro
Panel I R© (Serosep, Limerick, Ireland), the FilmArray R© GI panel
(BioFire, Inc., Salt Lake City, UT, USA), and the Seeplex R©
Diarrhea ACE Detection system (Seegene, Seoul, South Korea)
demonstrate similar sensitivities and specificities for STEC as the
GPP (Table 1).
A method of considerable interest that has yet to be clinically
evaluated for the detection of STEC from human stool is loop-
mediated isothermal amplification (LAMP). The assay uses a
DNA polymerase with strand-displacement activity and four
to six specially-designed primers to generate high numbers of
stem-loop amplicons in as little as 1 h at a stable temperature
of 60–65◦C; real-time visualization of positive reactions occurs
with the production of insoluble magnesium pyrophosphate,
thus obviating the need for fluorescent reporters (Notomi
et al., 2000; Mori and Notomi, 2009). Advantages of LAMP
include a high sensitivity and specificity, short turn-around-
time, isothermal conditions, and a simple detection method. Two
studies employed LAMP to detect STEC from human stool thus
far, neither determined sensitivities or specificities for the assays
used (Wang et al., 2012; Teh et al., 2014). However, a LAMP assay
developed by Hara-Kudo et al. (2007) to detect STEC, had 100%
sensitivity for stx1 and stx2, and a specificity of 98% for stx1 and
100% for stx2 in tests of stool samples at the Alberta ProvLab. As
well, the PPV for this assay was 92% for stx1and 100% for stx2
while both stx1 and stx2 had an NPV of 100%. Although, a major
disadvantage of LAMP is the difficulty in developing multiplex
assays, one could envision how the advantages of the LAMP assay
could be exploited in point-of-care testing. However as of yet,
more clinical evaluations are needed.
The Alberta ProvLab compared the diagnostic characteristics
and costs associated with five PCR assays (Chui et al., 2010).
This analysis showed that an in-house assay using the TaqMan R©
platformwith a rapid turn-around-time costs the least among the
real-time PCR assays, making it the most attractive test (Table 1;
Chui et al., 2010). This assay has been used by ProvLab to
determine the prevalence of STEC infections in various areas of
Alberta during 2006–2012 as well as to act as a comparator for
other methods of STEC detection (Chui et al., 2011, 2015b, 2013;
Couturier et al., 2011; Zelyas et al., 2016). As well, the Alberta
ProvLab is participating in the APPETITE (Alberta Provincial
Pediatric EnTeric Infection TEam) study, which is comparing
the GPP to routine detection methods in a large pediatric
cohort from 2014 to 2019 to better define the epidemiology
of gastrointestinal disease in Alberta (Freedman et al., 2015).
Since routine STEC detection methods in Alberta currently
involve only the identification of O157:H7 STEC through culture
methods, the use of the GPP during the APPETITE study will
greatly enhance STEC disease detection among children with
acute gastroenteritis and serve to further evaluate the diagnostic
value of the GPP.
AN ALGORITHM TO MAXIMIZE STEC
DETECTION
None of the aforementioned approaches is without drawbacks.
Culture techniques either lack sensitivity or a robust PPV, toxin
detection assays may yield false-positives and are often expensive,
and molecular methods tend to be laborious and/or expensive.
At the same time, each method has at least one advantage:
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culture allows the isolation of strains for typing; EIAs confirm
the production of disease-causing toxin and permit non-O157
STEC to be detected; and current nucleic acid tests have high
sensitivity and specificity for all STEC serotypes. As suggested
by the CDC in 2009, STEC detection algorithms are of most
utility if a combination of culture and non-culture methods are
used (Gould et al., 2009). One approach would be to pool clinical
specimens and test them initially using a non-culture method.
This would have the benefit of keeping costs low while screening
for a low-prevalence disease. Once a positive result is obtained,
the individual stools could be tested by the same non-culture
method to identify the STEC-positive specimen (Chou et al.,
2014). This would be followed by culture of the specimen on a
chromogenic agar to obtain the isolate for typing.
While the design of detection and characterization algorithms
may use various combinations of testing methods, the ultimate
goal for public health investigations of STEC are aimed at
specifically identifying “pathogenic” strains of STEC. However,
strategies to detect pathogenic STEC are hindered by a lack of a
consistent association between any single marker or combination
of markers and the severity of disease. Essentially, there exist
no absolute characteristic of pathogenic STEC, and therefore
testing algorithms need sufficient inclusivity to capture emerging
strains. As outlined by the 2013 European Food Safety Authority
(EFSA) criteria for assessing STEC pathogenicity, the O104
outbreak in 2011 revealed significant shortfalls in previous testing
algorithms. Specifically, algorithms that focus on identification
of a narrow panel of serogroups, virulence genes or reliance
on seropathotypes, which define the reported frequencies of
certain serotypes with human disease, are likely insufficient to
detect “non-typical” emerging STEC strains (EFSA BIOHAZ
Panel, 2013). As such, the O104 outbreak strain was not
included in any seropathotype category prior to 2011, and
screening strategies at the time required detection of stx and
eae before attempting to isolate the suspect STEC, therefore
missing O104, which was eae negative. Modifications to STEC
detection algorithms outlined by the EFSA include requirements
to attempt isolation of STEC from all samples positive for
stx genes. In addition, the EFSA panel also recommended
testing for the presence of aaiC (a secreted protein of EAEC)
and aggR (a plasmid-encoded regulator) genes associated with
enteroaggregative adhesion, which along with stx and eae
exhibit higher associated risk of severe disease. The continued
improvements in STEC identification and strategic testing
algorithms will aid epidemiological investigations and provide
early detection of future STEC outbreaks.
GENOMICS AND GENOTYPING IN
SURVEILLANCE
Once STEC is identified and isolated in culture, the next challenge
is to identify the relatedness of isolates for the purpose of public
health surveillance. As discussed, STEC isolates can be classified
initially based on the serotype, but additional typing is required to
determine if an isolate is related to another of the same serotype.
PFGE has been used extensively in public health to determine the
relatedness of isolates of many bacterial species including STEC.
For STEC, enhanced resolution can be achieved by combining
PFGE with MLVA or using PFGE alone. Networks of public
health laboratories accredited to run PFGE and/or MLVA report
to their regional PulseNet organization the profiles of organisms
they type (i.e., PulseNet International). This facilitates identifying
national or international outbreaks that would otherwise go
unnoticed. In our laboratory, this process through PulseNet
Canada and PulseNet USA has found cases linked to Albertan
foodborne outbreaks associated with the cross-border trade of
food products between different provinces of Canada and the two
countries (internal communications).
PFGE and MLVA have great utility in outbreak investigations
of STEC and are advantageous because they are amenable
to intra-laboratory comparison. However, for many types of
bacteria, these methods and others do not have adequate
resolution to identify outbreaks. WGS, on the other hand, has
been demonstrated in numerous cases to provide enhanced
resolution compared to pre-WGSmethods (Gilchrist et al., 2015)
because the entire genome (or most of the genome) can be
analyzed rather than just one or a few genetic elements. In
comparison to the current STEC typing and epidemiological
screening methods, WGS has superior discriminatory power for
comparable cost and would dramatically streamline the detection
and typing workflow by replacing the multiple tests required
for current investigations (Joensen et al., 2014; Dallman et al.,
2015a,b).
WHOLE GENOME SEQUENCING
Before discussing the studies demonstrating the utility of WGS
for STEC typing, one must be aware that multiple computing
methods exist to assess relatedness between a set of isolates. These
methods can be broadly categorized into those that analyze the
difference in single nucleotide variants (SNV) between isolates
(also referred to as single nucleotide polymorphisms [SNP]),
nucleotide differences, gene presence or absence throughout
the whole genome, gene allele differences, or overall genetic
similarity (e.g., k-mers, average nucleotide identity, and multiple
genome alignment; Konstantinidis et al., 2006; Sims et al., 2009;
Nielsen et al., 2011; Maiden et al., 2013; Leekitcharoenphon et al.,
2014). Once sequenced using a next-generation sequencer such
the IonTorrent
TM
(Thermo Fisher Scientific, Waltham, USA)1 or
HiSeq
TM
/MiSeq
TM
(Illumina Inc., San Diego, USA)2 platforms,
one or two files are generated depending on if single-end or
paired sequencing is done, respectively. The file(s) contain all the
“raw” sequence reads of the genomic fragments of ∼150–300 bp
in length, which can then be analyzed directly or assembled
into contigs to form a draft genome. The assembly can be done
with the help of a reference genome (e.g., E. coli O157:H7
1Thermo Fisher Scientific, Waltham, USA IonTorrentTM, Thermo Fisher
Scientific. Available online at: https://www.thermofisher.com/ca/en/home/brands/
ion-torrent.html (Accessed January 12, 2016).
2Illumina Inc., San Diego, USA Illumina Sequencing Platform Systems Portfolio.
Available online at: http://www.illumina.com/content/dam/illumina-marketing/
npiassets/PDF/brochure-sequencing-systems-portfolio.pdf (Accessed January 12,
2016).
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str. Sakai) or de novo. Most methods used to demonstrate
the utility of WGS in public health investigation of bacteria
have used assembly-based analysis. In general, assembly uses
one of more than 10 assemblers available, but microbiological
investigations, especially for Enterobacteriaceae, have generally
used Velvet or Burrows-Wheeler Aligner (Zerbino and Birney,
2008; Li and Durbin, 2009). Once assembled, the genome can
then be compared to other genomes to identify similarity. This
is the step in which there are the diverse aforementioned analysis
methods with each having multiple different software algorithms
and parameters in which to approach them. These approaches
are bundled into analysis “pipelines” in which a raw or assembled
genome sequence file can be inputted and subjected to multiple
software algorithms with specified settings (Kisand and Lettieri,
2013).
Most genome analysis pipelines require high performance
computing. There are, however, commercial methods emerging
that have optimized genome assembly and analysis to run
on high-performance desktop computers or utilize external
computing infrastructure to run the computationally intensive
steps. These commercial methods include: Bionumerics (Applied
Maths NV, Sint-Martens-Latem, Belgium)3, CLC Genomic
Workbench (Qiagen, Redwood City, CA, USA) and Ridom
TM
Seqsphere+ (Ridom GmbH, Münster, Germany)4. For SNV
analyses, there are also online web-interfaces that allow the user
to upload a set of sequence files and use a genomic center’s
computing infrastructure to run the software (e.g., SeqSero
[http://www.denglab.info/SeqSero] and the Center for Genomic
Epidemiology [http://www.genomicepidemiology.org]).
WGS IN STEC SURVEILLANCE
SNV analysis has been the predominant method used to date to
type isolates using WGS. Usually only the portion of the genome
that is conserved amongst a species or a specific pathovar is
used for determining strain relatedness (Tettelin et al., 2005;
Maiden et al., 2013). This type of analysis is coined “core SNV”
analysis to differentiate from SNV analysis of the entire genome.
Four groups have applied SNV analysis for the typing of STEC
for clinical public health purposes: ProvLab in collaboration
with PulseNet Canada and the Public Health Agency of Canada
National Microbiology Laboratory (PHAC-NML), the Danish
Center for Genomic Epidemiology, Health Protection Scotland
and Public Health England.
The Serum Staten Institute in Copenhagen, Denmark
sequenced 42 isolates received in a 7-week period and determined
their relationship using their web-based tools SNPtree and
NDtree (Joensen et al., 2014). During this study period they had
an outbreak with 13 cases of E. coli O157:H7, six of which were
included in their study. The NDtree method, an assembly-free
approach that compares the test isolates to nucleotide segments
of a reference genome and generates a score representing the
3Applied Maths NV, Sint-Martens-Latem, Belgium BioNumerics Seven: a unique
software platform | AppliedMaths. Available online at: http://www.applied-maths.
com/bionumerics (Accessed January 12, 2016).
4RidomGmbH,Münster, Germany Ridom SeqSphere+. Available online at: http://
www.ridom.de/seqsphere/u/User_Guide.html (Accessed January 12, 2016).
differences in nucleotides found between the genomes, was
able to distinguish the outbreak O157 isolates from the other
six O157 non-outbreak isolates and the other STEC serotypes.
The SNPtree method clustered all serotypes except for O117
K1:H7 together and found 29–65 SNVs different within the
outbreak O157 isolates and 521–753 SNVs different between
the outbreak and non-outbreak O157 isolates. This group also
demonstrated the ability of SNPtree and NDtree methods to
differentiate Salmonella Typhimurium strains from each other
(Leekitcharoenphon et al., 2014).
Public Health England has demonstrated that SNV
phylogenetic methods can accurately identify outbreak isolates
while adding increased sensitivity to current methods (MLVA
and epidemiological investigations in this case; Dallman et al.,
2015a). In one of their studies, 572 isolates received by the
Gastrointestinal Bacterial Reference Unit for typing including
randomly selected isolates from 2012 (n = 334) and 2013 (n =
147) were sequenced. Based on temporal and epidemiological
linkages, the maximum number of SNV differences for isolates
to be part of the same cluster was found to be five. An intriguing
part of this study was that SNV analysis identified two outbreaks
that were not detected by their routine epidemiological
investigations or MLVA typing, but were later found to have
previously unrecognized epidemiological linkages. This group
also demonstrated that SNV analysis was concordant with
epidemiological investigations in its ability to identify two
different outbreaks caused by watercress contaminated with E.
coli O157 from two different retailers (one supplied by imports
from North America and Europe and the other supplied from
south England; Jenkins et al., 2015). SNV analysis may also
be applicable to non-O157 because in one study of a nursery
school-associated E. coliO26:H11 outbreak,≤3 SNVs differences
were found in outbreak associated-isolates compared to ≥272
SNVs differences between outbreak and non-outbreak isolates
(Dallman et al., 2015b).
In Scotland, using SNVmethods, a 5-year retrospective review
of 105 E. coli O157 isolates and 11 epidemiologically linked
clusters, found that WGS was generally concordant with MLVA
(Holmes et al., 2015). In this study, epidemiologically linked
cases exhibited SNV differences of ≤4, while unrelated cases had
SNV differences between 9 and 1632. Two sets of isolates that
differed in only one MLVA locus were 32 and 126 SNVs different
from the other isolate in each set, demonstrating the increased
discriminatory power of WGS.
In 2014, Alberta had one of the largest outbreaks of E.
coli O157:H7 since monitoring by PulseNet Canada began in
2000 with a final tally of 119 clinical cases, which was linked
to pork consumption (ProMed-mail post 2759887, 2014). The
PHAC-NML SNVPhyl pipeline was used to detect SNV in 111
of these clinical cases and 6 environmental/food isolates and
was compared to the current protocol for identifying outbreaks,
which involves PFGE and MLVA profiling in combination with
epidemiological investigations (Sabat et al., 2013). Clinical, food
and environmental isolates from the pork-associated outbreak
were found to have ≤23 SNVs different from each other and
a minimum of 84 SNVs different from isolates not associated
with the outbreak, which included sporadic isolates, a concurrent
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smaller outbreak associated with a summer fair and a 2012
beef outbreak. The intra-outbreak SNV differences in the two
other outbreaks were 0–5 SNVs and it should be noted that
109 of the 117 sequenced pork outbreak isolates were also 0–
5 SNVs different from each other. The same isolates were also
subjected to k-mer analysis in which the genome is segmented
into nucleotide sequences of a pre-determined length (in this
case 25-mers) and the frequency of each k-mer in the entire
genome of each isolate is compared to the frequency of k-
mers in all other isolates to determine a k-mer phylogeny
tree. This analysis was able to cluster each outbreak into
separate nodes. Interestingly, the k-mer method was also able
to distinguish isolates from within the pork-associated outbreak
that lacked some virulence genes present in all other outbreak
isolates. The current surveillance methods and SNV analysis
could not distinguish the isolates missing virulence genes from
other isolates of the same outbreak. The difference between the
two WGS methods is likely because SNV analysis compares
conserved genomic regions where virulence factors are rarely
found, whereas k-mer analysis analyzes the entire genome.
WGS ANALYSIS APPROACHES
The ideal bacterial typing method should have the following
characteristics: accuracy, inter- and intra-laboratory
reproducibility, stability with multiple passaging of isolates,
high discriminatory power, concordance with epidemiological
data, speed, ease-of-use, cost effectiveness, and amenability to
computerized analysis (Van Belkum et al., 2007). WGS fulfills
many of these requirements while providing better accuracy and
discriminatory power than PFGE, MLVA and/or epidemiological
investigations combined. WGS is currently being used by Public
Health England for routine pathogen surveillance (Ashton et al.,
2015), and PulseNet Canada is currently setting up a similar
infrastructure. Before WGS becomes the international standard,
especially for networks such as PulseNet, many issues still need
to be addressed.
First of all, a comparison of the different software platforms
needs to be performed against a set of isolates with known
epidemiological and typing data. Although the studies discussed
herein demonstrate that different pipelines can cluster outbreak
isolates together with similar intra-outbreak SNV differences,
the performance of each pipeline should be tested using the
same set of isolates. Also, the SNV and k-mer analysis methods
are very computer intensive (k-mer more so than SNV) and
are not amenable to use by labs without the appropriate
computing infrastructure or expertise. If SNV and/or k-mer
methods were used as a standard, a new isolate would need to
be compared to a curated regional, national and/or international
database of isolates to place it into phylogenetic clusters,
similar to viral genotyping. Other options such as whole-
genome or core genome multi-locus sequence typing (wg or
cgMLST), which look at most or all genes in an organism’s
genome, can create a barcode by assigning numbers for allelic
variants and can be run on a desktop computer (Kohl et al.,
2014; Leopold et al., 2014; Ruppitsch et al., 2015). Once a
wgMLST database for E. coli is developed in PulseNet, it could
become a strong contender for the standard WGS typing
of STEC.
Once standards and issues surrounding the computing power
and expertise are resolved, WGS will supplant current typing
methods for STEC and most other organisms. It can also replace
serotyping of STEC and typing of stx genes (Joensen et al.,
2014, 2015) while providing the additional benefits of using
the sequence for detecting virulence genes other than stx and
providing data for research into genetic elements that influence
pathogenicity. Finally, if the methods to perform metagenomics
on stool are refined, WGS may also replace PCR or selective
agars as the initial screening mechanism for STEC and other
enteric pathogens. However, there remain significant technical,
economic and organizational hurdles to overcome, before the
practical use of genome-wide typing and analysis approaches in
routine STEC investigations become a reality (Köser et al., 2012;
Franz et al., 2014).
EXPERIENCES AT THE ALBERTA
PROVLAB
There have been continuous improvements in STEC detection
through bacterial culturing, immunochemistry, and molecular
and genomic methods. The advancements in each of these
methods aim to increase assay sensitivity, specificity, speed,
throughput and broad-ranging strain inclusivity. Despite the
improvements in commercial assays and technologies, the
adoption of detection methods that encompass non-O157
STEC serotypes by frontline laboratories has been slow. For
this reason, there is likely to be a continued significant
underreporting of STEC infections in current surveillance
data in many countries. At the Alberta ProvLab, multiple
studies of regional STEC rates and serotypes revealed that a
diverse range of serotypes exist among non-O157 STEC in
the province; 99% of these were identified by culture method
and included O157 (n = 99), top six (n = 45), and non-
top six (n = 36) (Chui et al., 2011, 2015a,b; Couturier
et al., 2011). Most of the non-O157 STEC identified would
not have been detected by routine frontline testing, which
is restricted to detect only O157 STEC. Notably, between
8.3 and 52.9% of the non-O157 serotypes identified in these
studies were positive for Stx2. Therefore, these findings reveal
the underreporting of non-O157 STEC and the potentially
pathogenic strains that risk being undetected in the population
(Couturier et al., 2011; Chui et al., 2011, 2015a,b; Gould et al.,
2013).
CONCLUSION
There has been much dialog surrounding strategies for more
comprehensive STEC identification by frontline laboratories.
Primarily these approaches focus on the inclusion of Stx
typing in routine testing. More recently, the development and
incorporation of WGS methods in STEC surveillance aim
to improve the epidemiological tracking of infections. As a
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secondary benefit of adopting WGS, will be a enhancement in
our understanding of STEC biology through the vast collection
of genome sequences. Although, there is great promise in WGS
in STEC characterization and surveillance, STEC detection will
likely continue to rely on a combination of culturing and non-
culture methods. As such, regardless of the technologies that
arise for STEC detection and characterization, for at least the
immediate future, frontline laboratories will continue to need
logical testing algorithms that incorporate a selection of the
appropriate methods above.
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